Professor Hawcutt is a paediatric clinical pharmacologist at the University of Liverpool, and honorary consultant in paediatrics at Alder Hey Children’s Hospital. He is Director of Research at Alder Hey Children's Hospital, and Director of the NIHR …

Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre … CD Russell, CJ...

Professor Hawcutt delivers paediatric clinical services at Alder Hey Children's Hospital, including rapid access general paediatric clinics, and the UKs first paediatric clinical pharmacology service (looking at drug optimisation and deprescribing).

2024年2月15日 · Dr Dan Hawcutt – CRF Director. The clinical lead on the CRF, Dr Hawcutt is one of six consultant paediatric clinical pharmacologists in the UK, and the only one engaged with early-phase paediatric clinical trials.

Laser-cutting: A novel alternative approach for point-of-care manufacturing of bespoke tablets. Intravenous Vitamin C for Patients Hospitalized With COVID-19: Two Harmonized Randomized Clinical Trials. Female paediatric patients with epilepsy who …

Dan Hawcutt studies Pharmacogenetics, Neuromodulation, and Molecular Imaging. Dr Hawcutt is a senior lecturer in paediatric pharmacology at the University of Liverpool, and honorary consultant in paediatrics at Alder Hey Children’s Hospital.

Dr Hawcutt is a senior lecturer in paediatric pharmacology at the University of Liverpool, and honorary consultant in paediatrics at Alder Hey Children’s Hospital. He is the clinical lead on the NIHR Alder Hey Clinical Research Facility, undertaking early …

Comprehensive list of the editorial board for Archives of Disease in Childhood, including editor in chief, associate editors & social media advisors.

2024年3月13日 · Dan Hawcutt, MD MRCPCH is a reader in pediatric pharmacology at the University of Liverpool, and honorary consultant in pediatrics at Alder Hey Children’s Hospital. He is the director of Alder Hey’s early-phase clinical research facility, overseeing early-phase drug trials, and testing medicines, including steroids.